Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age? (Q33837320)

29 July 2017

1 reference

title

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age? (English)

1 reference

29 July 2017

1 reference

1 reference

Cunningham D

1 reference

29 July 2017

Daniele B

1 reference

29 July 2017

Simmonds PD

series ordinal

1 reference

29 July 2017

Best LY

series ordinal

1 reference

29 July 2017

Ross PJ

series ordinal

1 reference

29 July 2017

publication date

1 November 1999

1 reference

European Journal of Cancer

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

1640-1649

1 reference

Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Cancer in older persons. Magnitude of the problem--how do we apply what we know?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Survival of colorectal cancer patients in Europe during the period 1978–1989

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Relative survival in elderly cancer patients in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Colon cancer in the elderly: evidence for major improvements in health care and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastroint

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

Validation of a multidimensional evaluation scale for use in elderly cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900185-9

7 January 2021

10.1016/S0959-8049(99)00185-9

Identifiers

DOI

1 reference

29 July 2017

1 reference